Journal of Oncology / 2009 / Article / Tab 3

Research Article

A Population-Based Clinical Trial of Irinotecan and Carboplatin

Table 3

Dose-limiting grade III/IV toxicities (N = 50).

ToxicitiesNumber of patients (%)

Neutropenia29 (58)
Thrombocytopenia8 (16)
Diarrhea4 (8)
Nausea/emesis4 (8)
Asthenia2 (4)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.